Hyungsuk Roh

MS/Ph.D combined (2024. 03-present)

1. Kim, Y.,* Mun, J., Kim, E., Roh, H., Eom, S., Jun, H., Kim, H. J., Kim, M., Jeon, J. P., Park, S. H., Min, D.,* and Kang, S.,* Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth . Nano Today, 2025, 65, 102834.